Sacrum

Remedium Healthcare Products Launches NuVeria Labs' Groundbreaking Sacral Silicone Dressing, Now Available for Purchase on Amazon Prime

Retrieved on: 
Saturday, April 20, 2024
Foam, Patient, Sacrum, Knowledge, Caregiver

NORTHBROOK, Ill., April 19, 2024 /PRNewswire-PRWeb/ -- Remedium Healthcare Products is proud to announce the launch of NuVeria Labs' revolutionary Sacral Silicone Dressing, now available for purchase on Amazon, bringing advanced wound care solutions directly to consumers' doorsteps.

Key Points: 
  • Remedium Healthcare Products announces the launch of NuVeria Labs' Sacral Silicone Dressing on Amazon, setting a new standard in accessible, advanced wound care
    NORTHBROOK, Ill., April 19, 2024 /PRNewswire-PRWeb/ -- Remedium Healthcare Products is proud to announce the launch of NuVeria Labs' revolutionary Sacral Silicone Dressing, now available for purchase on Amazon, bringing advanced wound care solutions directly to consumers' doorsteps.
  • "Our commitment at Remedium Healthcare Products is to provide patients and caregivers with innovative and effective healthcare solutions," said Vlad Anastasov, President of Remedium Healthcare Products.
  • NuVeria Labs' by Remedium Healthcare Products demonstrates a shared dedication to bridging the gap between clinical efficacy and accessibility.
  • Experience the difference today and discover why NuVeria Labs, under the ownership of Remedium Healthcare Products, is the preferred choice for innovative wound care solutions.

WOVEN ORTHOPEDICS SECURES SECOND FDA SPINE CLEARANCE - OGMEND® NOW AVAILABLE FOR MOST PEDICLE SCREW DIAMETERS

Retrieved on: 
Thursday, February 29, 2024
Commercial director, FDA, Food, Surgeon, Sacrum, Journal, Publication, Telescopic sight

MANCHESTER, Conn., Feb. 29, 2024 /PRNewswire/ -- Woven Orthopedic Technologies, developer of Ogmend®, a simple implantable sleeve that quickly and easily secures stable screw fixation, has received its second 510(k) clearance from the Food and Drug Administration (FDA) for the use of Ogmend® Implant Enhancement System in spine surgery.

Key Points: 
  • MANCHESTER, Conn., Feb. 29, 2024 /PRNewswire/ -- Woven Orthopedic Technologies, developer of Ogmend®, a simple implantable sleeve that quickly and easily secures stable screw fixation, has received its second 510(k) clearance from the Food and Drug Administration (FDA) for the use of Ogmend® Implant Enhancement System in spine surgery.
  • Prominent industry groups and publications, including AO, the Journal of Neurosurgery, and the International Spine Study Group, have reported the complexities encountered in spinal surgeries, particularly in the lower lumbar and sacral segments.
  • These areas are commonly stabilized with larger diameter screws given their larger bone structure and the greater forces endured.
  • The resulting stresses placed on these screws can create challenges for surgeons that call for the use of special techniques and tools.

Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral Screw

Retrieved on: 
Wednesday, February 28, 2024
State College, Pennsylvania, Physician, Marketing, FDA, Quality of life, Food, 3D, Sacrum, Ilium, Chronic pain, Patient

REDWOOD CITY, Calif., Feb. 28, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that the U.S. Food and Drug Administration (FDA) cleared its sacroiliac joint fusion device, which will be marketed as Nevro1, without the need to include the screw ("NevroFix™").

Key Points: 
  • Nevro1, an integrated transfixing technology, is proven to immediately transfix the SI joint to allow the opportunity for long-term fusion.
  • Self-contained, deployable titanium anchors transfix the sacrum and ilium to enhance axial and rotational stability of the joint.
  • In addition, Nevro's proprietary instrumentation allows for optimal intra-articular SI joint preparation which is critical to achieve joint fusion.
  • The company encourages investors and potential investors to consult the Nevro website regularly for important information about Nevro.

Spinal Simplicity Announces 510(K) FDA Clearance of Its Novel Sacroiliac Joint System, the Liberty-SI Lateral Implant

Retrieved on: 
Monday, December 11, 2023
Simplicity, Arthrodesis, Anesthesia, Patient, FDA, Sacrum, Spine, Sacroiliac joint, Titanium, Ilium, Today, Physician, Medical device, Dentistry, Marketing, Neuroscience

OVERLAND PARK, Kan., Dec. 11, 2023 /PRNewswire-PRWeb/ -- Today, Spinal Simplicity is pleased to announce the U.S. Food & Drug Administration (FDA) 510(K) clearance of the Spinal Simplicity Liberty-SI Lateral Implant System; a transfixing, lateral sacroiliac (SI) joint fusion system. The Liberty-SI Lateral Implant System is intended for sacroiliac joint fusion for conditions including sacroiliac disruptions and degenerative sacroiliitis.

Key Points: 
  • Spinal Simplicity's Liberty-SI Lateral Implant System is a revolutionary sacroiliac joint fusion technology designed for safer and potentially less invasive treatment of sacroiliac disruptions and degenerative sacroiliitis.
  • OVERLAND PARK, Kan., Dec. 11, 2023 /PRNewswire-PRWeb/ -- Today, Spinal Simplicity is pleased to announce the U.S. Food & Drug Administration (FDA) 510(K) clearance of the Spinal Simplicity Liberty-SI Lateral Implant System ; a transfixing, lateral sacroiliac (SI) joint fusion system.
  • The Liberty-SI Lateral Implant System is intended for sacroiliac joint fusion for conditions including sacroiliac disruptions and degenerative sacroiliitis.
  • The lateral surgical technique first decorticates the bone, preparing the joint for fusion.The Liberty-SI implant is designed to achieve arthrodesis of the SI joint using a lateral technique that passes through the ilium across the sacroiliac joint and into the sacrum, thus transfixing the sacroiliac joint.

Silony Medical completes acquisition Centinel Spine's Global Fusion Business

Retrieved on: 
Thursday, October 19, 2023
Sacrum, Spinal fusion, Spine, European Technology Platform on Smart Systems Integration, Acquisition, IBF, Instrumented posterior lumbar interbody fusion, Surgeon, Freedom, 3D printing, Bookbinding

The completed transaction includes all cervical and lumbar fusion products, including the STALIF® technology platform

Key Points: 
  • The completed transaction includes all cervical and lumbar fusion products, including the STALIF® technology platform
    FRAUENFELD, Switzerland, Oct. 19, 2023 /PRNewswire/ -- Silony Medical International AG (the company), a growing challenger to "big medtech" in the global spinal fusion market, has completed the acquisition of Centinel Spine's Global Fusion Business.
  • This combines Silony's Verticale® posterior screw & rod fusion Platform, its Roccia® and Favo® Interbody Fusion (IBF) Systems with the STALIF® Technology Platform to create a first in class occiput to sacrum, posterior, lateral and anterior Spinal Fusion Portfolio for open & minimally invasive spinal fusion cases.
  • Silony has been active in the US market since late 2018 - with this acquisition, Silony will capitalize on the great team and distribution network of the Centinel Fusion Portfolio to strengthen its position in the North American Spine Market to bring surgeons and their teams first in class spine fusion solutions that offer flexibility and freedom.
  • In the coming days and months, Silony will change its name to Silony Spine to underscore its 100% commitment & focus on spine fusion technology solutions.

Silony Medical completes acquisition Centinel Spine's Global Fusion Business

Retrieved on: 
Thursday, October 19, 2023
Sacrum, Spinal fusion, Spine, European Technology Platform on Smart Systems Integration, Acquisition, IBF, Instrumented posterior lumbar interbody fusion, Surgeon, Freedom, 3D printing, Bookbinding

The completed transaction includes all cervical and lumbar fusion products, including the STALIF® technology platform

Key Points: 
  • The completed transaction includes all cervical and lumbar fusion products, including the STALIF® technology platform
    FRAUENFELD, Switzerland, Oct. 19, 2023 /PRNewswire/ -- Silony Medical International AG (the company), a growing challenger to "big medtech" in the global spinal fusion market, has completed the acquisition of Centinel Spine's Global Fusion Business.
  • This combines Silony's Verticale® posterior screw & rod fusion Platform, its Roccia® and Favo® Interbody Fusion (IBF) Systems with the STALIF® Technology Platform to create a first in class occiput to sacrum, posterior, lateral and anterior Spinal Fusion Portfolio for open & minimally invasive spinal fusion cases.
  • Silony has been active in the US market since late 2018 - with this acquisition, Silony will capitalize on the great team and distribution network of the Centinel Fusion Portfolio to strengthen its position in the North American Spine Market to bring surgeons and their teams first in class spine fusion solutions that offer flexibility and freedom.
  • In the coming days and months, Silony will change its name to Silony Spine to underscore its 100% commitment & focus on spine fusion technology solutions.

VGI Medical, LLC Announces The Launch of the new SiJoin® Transfixing Triangular Trabecular Titanium (T4) Implant System, for Sacroiliac Joint Transfixation, at NASS 2023

Retrieved on: 
Wednesday, October 18, 2023
3D, Sacrum, US, US FDA, SI, Rotation, Multimedia, Quality of life, University, VGI, Pain, Patient, Ilium, University of Toledo, NASS, Medical device, 3D printing

LARGO, Fla., Oct. 18, 2023 /PRNewswire-PRWeb/ -- VGI Medical, LLC launches the new US FDA 510(k) cleared SiJoin® Transfixing Triangular Trabecular Titanium (T4) Implant System. The transfixing SiJoin® T4 Implant is made from Ti-6AI-4V ELI titanium alloy using an additive manufacturing process, where the porous trabecular construction is engineered to mimic cancellous bone structure. The implant has an engineered lattice design to achieve 500-700 mm pores, and has undergone post processing to create micro and nano surface structures facilitating the proliferation of osteoblast adhesion and bony in-growth. The SiJoin® T4 Implant is engineered with a dual geometric shape designed to be simultaneously positioned within the illium and sacrum, through the respective cortical wall, providing high surface area contact for fixation. The implant is held against rotation via the stabilizer fins positioned between the opposing illium and sacrum surfaces, and the non-circular cross-section of the main body. The patented novel design of the SiJoin® T4 Implant fixes the sacrum and ilium relative to one another, maintaining the anatomical spacing of the SI joint, providing mechanical support by transfixing the SI joint while biologic fusion occurs.

Key Points: 
  • VGI Medical, LLC announces the launch of the new SiJoin® Transfixing Triangular Trabecular Titanium (T4) Implant System.
  • VGI's superior engineering and testing has allowed them to design a titanium alloy implant for use in alleviating sacroiliac joint pain and create a simplified process for the surgeon.
  • LARGO, Fla., Oct. 18, 2023 /PRNewswire-PRWeb/ -- VGI Medical, LLC launches the new US FDA 510(k) cleared SiJoin® Transfixing Triangular Trabecular Titanium (T4) Implant System.
  • The transfixing SiJoin® T4 Implant is made from Ti-6AI-4V ELI titanium alloy using an additive manufacturing process, where the porous trabecular construction is engineered to mimic cancellous bone structure.

SurGenTec® Unveils TiLink™—Revolutionary Posterior Sacroiliac Fusion System Featuring Novel Compression Capability

Retrieved on: 
Tuesday, October 3, 2023
Surgery, Medical Devices, FDA, Hospitals, Health Technology, Biotechnology, Physical Therapy, Health, General Health, SI, Surgeon, Ilium, Arthralgia, 3D, Spine, Hope, Multimedia, Pathology, Patient, Physician, Sacroiliac joint, Sacrum, Synovial joint, Safety, Medical device

Orthopedic compression technologies have long been utilized in various surgical procedures, such as long bone fixation, spinal stabilization, foot/ankle, etc.

Key Points: 
  • Orthopedic compression technologies have long been utilized in various surgical procedures, such as long bone fixation, spinal stabilization, foot/ankle, etc.
  • Until now, the industry had struggled to achieve effective posterior compression across the sacroiliac joint.
  • SurGenTec’s latest innovation now offers a proven method for providing significant compression across the sacroiliac joint to aid in healing.
  • "We are thrilled to introduce TiLink Posterior Sacroiliac Joint Fusion System," said Travis Greenhalgh, Chief Executive Officer at SurGenTec.

Aurora Spine Announces Full Release of its SiLO TFX™ MIS Sacroiliac Joint Fixation System

Retrieved on: 
Wednesday, September 13, 2023
Aurora, ASG, Silo, Sacrum, Ilium, TFX, Sacroiliac joint, Engineering, Marketing, Operation

Carlsbad, Calif., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, announced today that it is in full commercial release of its proprietary SiLO TFX™ MIS Sacroiliac Joint Fixation Device system.

Key Points: 
  • Carlsbad, Calif., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, announced today that it is in full commercial release of its proprietary SiLO TFX™ MIS Sacroiliac Joint Fixation Device system.
  • The patented, minimally invasive SiLO TFX MIS Sacroiliac Joint Fixation System is intended for sacroiliac joint fusion for conditions including sacroiliac joint disruptions and degenerative sacroiliitis.
  • The SiLO TFX MIS Sacroiliac Joint Fixation System includes a Transfixing-Cone, an ilium screw, a sacrum screw and associated instrumentation.
  • I am pleased with the teamwork between Engineering, Operations and Marketing on the full release of the SiLO TFX system."

Silony Medical acquires Centinel Spine's Global Fusion Business

Retrieved on: 
Thursday, September 7, 2023
Spinal fusion, IBF, European Technology Platform on Smart Systems Integration, Ubiquitin A-52 residue ribosomal protein fusion product 1, Samuel Bryan, Sacrum, Health, Instrumented posterior lumbar interbody fusion, 3D printing

FRAUENFELD, Switzerland, Sept. 7, 2023 /PRNewswire/ -- Silony Medical International AG (the company), a growing challenger to "big medtech" in the global spinal fusion market, has signed a definitive agreement to acquire Centinel Spine's Global Fusion Business.  This combines Silony's Verticale® posterior screw & rod fusion System, its Roccia® and Favo® Interbody Fusion (IBF) Systems with the STALIF® Technology Platform to create a first in class occiput to sacrum, posterior, lateral and anterior Spinal Fusion Portfolio for open & minimally invasive spinal fusion cases.

Key Points: 
  • The transaction includes all cervical and lumbar fusion products, including the STALIF® technology platform
    FRAUENFELD, Switzerland, Sept. 7, 2023 /PRNewswire/ -- Silony Medical International AG (the company), a growing challenger to "big medtech" in the global spinal fusion market, has signed a definitive agreement to acquire Centinel Spine's Global Fusion Business.
  • This combines Silony's Verticale® posterior screw & rod fusion System, its Roccia® and Favo® Interbody Fusion (IBF) Systems with the STALIF® Technology Platform to create a first in class occiput to sacrum, posterior, lateral and anterior Spinal Fusion Portfolio for open & minimally invasive spinal fusion cases.
  • "Adding Centinel's Fusion Products to Silony's portfolio significantly strengthens our technological and geographic footprint, without cannibalizing products and sales regions" said Silony CEO Constantin Schoen.
  • Silony is committed to successful long-term relationships, and we look forward to continuing to work with the established STALIF® distributor, surgeon and hospital partners around the world.